Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

Balko, Justin M, Cook, Rebecca S, Vaught, David B, Kuba, María G, Miller, Todd W, Bhola, Neil E, Sanders, Melinda E, Granja-Ingram, Nara M +10 more·2012·Nature Medicine

DOI 10.1038/nm.2795

Cited by (264)

Items 201–264 of 264

Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations
Yi‐Zhou Jiang, Li‐Ping Ge, Xi Jin, Lei Fan, Min Yi He, Yin Liu, Li Chen, Wen‐Jia Zuo, Jiong Wu, Guang‐Yu Liu et al. · 2020 · Breast Cancer Research and Treatment
Development and application of novel BiFC probes for cell sorting based on epigenetic modification
Agnes Mendonca, Oscar Fernando Sánchez, Han Zhao, Li Lin, Alan Min, Chongli Yuan · 2022 · Cytometry Part A
The clinical significance of receiving a kidney allograft from deceased donor with chronic histologic changes
Ibrahim Batal, Geo Şerban, Sumit Mohan, Syed A. Husain, Elena Rodica Vasilescu, Russel J. Crew, Geoffrey K. Dube, Pedro Rodrigo Sandoval, Shana M. Coley, Dominick Santoriello et al. · 2021 · Modern Pathology
Biology and Treatment of Basal-Like Breast Cancer
Bingchen Han, William Audeh, Yanli Jin, Sanjay Prakash Bagaria, Xiaojiang Cui · 2013 · Humana Press eBooks
H3K27me3 is a determinant of chemotolerance in triple-negative breast cancer
Justine Marsolier, Pacôme Prompsy, Adeline Durand, Anne-Marie Lyne, Camille Landragin, Amandine Trouchet, Sabrina Tenreira Bento, Almut S. Eisele, Sophie Foulon, Léa Baudre et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Mechanisms of Tissue Injury in Cryosurgery
John G. Baust, Kimberly L. Santucci, Kristi K. Snyder, Anthony T. Robilotto, John M. Baust · 2023
Cellular and clinical impact of protein phosphatase enzyme epigenetic silencing in multiple cancer tissues
Edward Wiltshire, Manuel Castro de Moura, David Piñeyro, Ricky S. Joshi · 2024 · Human Genomics
Structural and Functional Insights into Targeting GCCG Sites in the EGFR Promoter by Two DNA Intercalators to Inhibit Breast Cancer Metastasis
Chih-Chun Chang, Hsin‐Ju Li, Roshan Satange, Shanmeng Lin, Tai‐Lin Chen, Chi‐Chen Lin, Stephen Neidle, Ming‐Hon Hou · 2025 · Journal of Medicinal Chemistry
A phase Ib/II trial of atezolizumab with cobimetinib or idasanutlin in metastatic estrogen receptor positive breast cancer
Jessica Mezzanotte-Sharpe, Brandie C. Taylor, Paula I. González Ericsson, Violeta M. Sanchez, Andres A. Ocampo, Jacey L. Marshall, Julia A. Steele, Melinda E. Sanders, Ingrid A. Mayer, Justin Micah Balko et al. · 2025 · npj Breast Cancer
Dual-Specificity Map Kinase (MAPK) Phosphatases (MKPs) and Their Involvement in Cancer
Andrew M. Kidger, Stephen M. Keyse · 2016 · Springer eBooks
Molecular Subtyping and Outlier Detection in Human Disease Using the Paraclique Algorithm
Ronald D. Hagan, Michael Allen Langston · 2021 · Algorithms
Epigenetic Mechanisms in the Regulation of Drug Metabolism and Transport
Óscar Teijido · 2019 · Elsevier eBooks
The collagenase of the bacterium Clostridium histolyticum does not favor metastasis of breast cancer
Yannick Fabian Diehm, Katharina Marstaller, Anna-Maria Seckler, Martin Reinhold Berger, Michael Zepp, Matthias M. Gaida, Julia Thomé, Dimitra Kotsougiani, Ulrich Kneser, Sebastian Fischer · 2022 · Breast Cancer
Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben Moshe, Anya Pavlovski, Rinat Bernstein‐Molho et al. · 2025 · Molecular Oncology
Ubiquitin-mediated stabilization of KDM5B drives chemoresistance via repression of dual-specificity phosphatase 4 in ovarian cancer
Jung Hoan Yoo, Go Woon Kim, Yu Hyun Jeon, Jaewook Kim, Enzhi Luo, S.C. Lee, Soo Yeon Oh, Junjeong Choi, Kuglae Kim, So Hee Kwon · 2026 · Signal Transduction and Targeted Therapy
X-box binding protein 1 (XBP1): a potential role in chemotherapy response, clinical pathologic features, non-inflamed tumour microenvironment for breast cancer
Zhipeng Zhu, Hongliang Zhan, Anran Sun, Heqing Huang, Baisheng Chen, Fuxing Zhang · 2022 · Bioscience Reports
PEGylated Titanium Dioxide Nanoparticle-bound Doxorubicin and Paclitaxel Drugs Affect Prostate Cancer Cells and Alter the Expression of DUSP Family Genes
Zuhal Tunçbilek, Neşe Keklikçioğlu Çakmak, Ayça Taş, Durmuş Ayan, Yavuz Siliğ · 2024 · Anti-Cancer Agents in Medicinal Chemistry
Integration of network pharmacology, transcriptomics, and experimental verification to investigate the mechanism of action of cepharanthine hydrochloride against prostate cancer
Zongming Dong, Xiaosa Chang, Xing Luo, Hui Li, Ming Deng, Zeyu Huang, Tingting Chen, Yu Chen, Bishao Sun, Yingbing Wu et al. · 2025 · Scientific Reports
Treating Triple-Negative Breast Cancer: Where Are We?
Aki Morikawa, Andrew David Seidman · 2015 · Journal of the National Comprehensive Cancer Network
Application of Transcriptomics in Exposed Human Populations: Benzene as an Example
Cliona M. McHale, Martyn T. Smith, Luoping Zhang · 2016 · Royal Society of Chemistry eBooks
Novel protective role for MAP kinase phosphatase 2 in inflammatory arthritis
Juliane Schroeder, Kirsty Ross, Kathryn McIntosh, Shilan Jabber, Stuart Woods, Jenny Crowe, Janet C. Patterson‐Kane, James K Alexander, Catherine E. Lawrence, Robin J. Plevin · 2019 · RMD Open
Three-dimensional electron microscopy uncovers mitochondrial network remodeling in residual triple negative breast cancer persisting after conventional chemotherapy treatments
Mariah J. Berner, Heather K. Beasley, Benjamin Rodriguez, Audra Lane, Steven W. Wall, Andrea Gail Marshall, Zer Vue, Larry Vang, Mokryun L. Baek, Mason Killion et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
A novel survival prediction signature outperforms PAM50 and artificial intelligence-based feature-selection methods
Reuben Jyong Kiat Foo, Siqi Tian, Ern Yu Tan, Wilson Wen Bin Goh · 2023 · Computational Biology and Chemistry
Expression levels of some genes in the MAPK pathway ( DUSP1 , DUSP2 , DUSP4 , DUSP6 and DUSP10 ) in eyelid tumor tissue
Esma Özmen, Ayça Taş, Dilara Fatma Akın, Haydar Erdoğan, Yavuz Siliğ · 2024 · Turkish Journal of Biochemistry
Co-occurrence of transcriptionally distinct persister cell states underpins neoadjuvant therapy resistance in triple‑negative breast cancer
Yu Zhang, Fatemeh Ahmadi Moughari, Ioanna Mavrommati, Nora Julia Doleschall, Kate Moore, Gareth Muirhead, Ramprasad Srinivasan, Ping Gong, Jonathan Thomas Lei, Amy Fleming et al. · 2026 · Genome Medicine
The Story of Adjuvants to Boost the Performance of Cryoablation
Kimberly L. Santucci, John M. Baust, Kristi K. Snyder, Anthony T. Robilotto, Robert G. VanBuskirk, John G. Baust · 2017 · Current clinical urology
Triple-Negative Breast Cancer: One Or More Entities?
Alexios Matikas, Georgios Theodoros Lazaridis, Sofia Agelaki · 2014 · Forum of Clinical Oncology
Apoptosis-inducing effect of 6,7-dimethoxy-4'-hydroxy-8- formylflavon from Nicotiana tabacum L leaf in human hepatoma HepG2 cells via activation of mitochondriamediated apoptotic pathway
Qiujie Zhang, Wensheng Qiu, Hongxia Cui, Yu Zhuang, Ruyong Yao, Shihai Liu, Zimin Liu, Jun Liang · 2018 · Tropical Journal of Pharmaceutical Research
Exploring molecular links between obesity and breast cancer.
Rebekah Crake · 2015 · Otago University Research Archive (University of Otago)
Integration of multi-omics data shows downregulation of mismatch repair, purin, and tublin pathways in AR-negative triple-negative chemotherapy-resistant breast tumors
Xiaojia Tang, Kevin J. Thompson, Krishna R. Kalari, Jason P. Sinnwell, Vera Jean Suman, Peter T. Vedell, Sarah A. McLaughlin, DW Northfelt, Alvaro Moreno Aspitia, Richard J. Gray et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition
Nazia Chaudhary, Bhagya Shree Choudhary, Sushmita Patra, Shivani Malvankar, Anusha Shivashankar, Eeshrita Jog, Vaishali V. Kailje, Sonal Khanna, Subhakankha Manna, Sarthak Sahoo et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Epigenetic Alterations in Endocrine-Dependent Cancers: Implications of Endocrine Dysfunctions
Geneviève Deblois, Mathieu Lupien · 2016 · Elsevier eBooks
Kruppel-like factor 4 (KLF4) regulates protumorigenic signaling in triple-negative breast cancer (TNBC) cells
Sriganesh B. Sharma · 2015
Omics of Hereditary Breast Cancer
Catherine A. Moroski-Erkul, Burak Yılmaz, Esra Gündüz, Mehmet Gündüz · 2014 · Springer eBooks
Targeting the Triple-Negative Breast Cancer Kinome with Chemical Proteomics
Martin C. Whittle · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
The role of microRNAs in chronic lung allograft dysfunction
Shameem S. Ladak · 2018
Molecular Mechanisms of Chemotherapy Resistance in Oestrogen Receptor Positive Breast Cancer
Diana E. Baxter · 2019 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Molecular Subtyping in Human Disease Using the Paraclique Algorithm
Ronald D. Hagan, Michael Allen Langston · 2019 · Communications in computer and information science
Predicting the outcome of oral potentially malignant disorders using a composite clinical, histopathological and molecular classifier
Hans Prakash Sathasivam · 2018
Expression analysis of colon adenocarcinoma in the South Indian population reveals novel signals of pathogenesis
Prasanth S. Ariyannur, Reenu Anne Joy, Veena P. Menon, Roopa Rachel Paulose, Keechilat Pavithran, Damodaran Madhavi Vasudevan · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
ハムスターの迷路学習 : 「教育心理学」課題レポート
瑞希篠原 · 2013 · 保育研究
Expression And Regulation Of Map Kinase Phosphatases 1 And 2 In Breast Cancer Tamoxifen Sensitivity
Kelly K. Haagenson · 2013 · Human Biology
Faculty Opinions recommendation of Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors.
Michael Cole, John W. Hinds · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Preoperative Therapy for Operable Breast Cancer
Yeşim Eralp · 2019 · Springer eBooks
Faculty Opinions recommendation of Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma.
Fabio Marra, Alessandra Gentilini · 2021 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Cellular and clinical impact of Protein Phosphatase Enzyme epigenetic silencing in multiple cancer tissues
Ricky S. Joshi, Manel Esteller · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Integration of multi-omics data shows downregulation of mismatch repair, purin, and tubulin pathways in triple-negative chemotherapy-resistant breast tumors
Xiaojia Tang, Kevin J. Thompson, Krishna R. Kalari, Jason P. Sinnwell, Vera Jean Suman, Peter T. Vedell, Sarah A. McLaughlin, DW Northfelt, Alvaro Moreno Aspitia, Richard J. Gray et al. · 2022 · Research Square
Research on the Effects of Chemotherapy on Survival Outcomes for Older Patients with Primary Triple-Negative Breast Cancer after Surgery: A Propensity Score Matching and Competing Risk Analysis of the SEER Database
Chongwu He, Jing Chen, Bing Hu, Ming Jiang, Ru Chen, Jianglong Li, Gongxian Wang, Tenghua Yu · 2023 · Clinical and Experimental Obstetrics & Gynecology
Supplementary Data from Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer
Jennifer B. Dennison, Jennifer R. Molina, Shreya Mitra, Ana Maria Gonzalez-Angulo, Justin Micah Balko, Maria Gabriela Kuba, Melinda E. Sanders, Joseph A. Pinto, Henry Gómez, Carlos L. Arteaga et al. · 2023
Supplementary Data from Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer
Jennifer B. Dennison, Jennifer R. Molina, Shreya Mitra, Ana Maria Gonzalez-Angulo, Justin Micah Balko, Maria Gabriela Kuba, Melinda E. Sanders, Joseph A. Pinto, Henry Gómez, Carlos L. Arteaga et al. · 2023
The potential of Senicapoc, a KCNN4 inhibitor, for the prevention and treatment of breast cancer
Christos Xiao, Mariska Sauzine Miranda, Wei Shi, Jonathan Beesley, Jodi M. Saunus, Andrew Civitarese, Debra M. Black, Meagan Ruppert, Melrine Pereira, Susan Jackson et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Additional file 1 of Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer
Ann Hanna, Mellissa J. Nixon, Estrada, M. Valeria, Sanchez, Violeta, Quanhu Sheng, Susan R. Opalenik, Abigail L. Toren, Bauer, Joshua, Philip Owens, Frank M. Mason et al. · 2022 · Figshare
Additional file 1 of Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR
Tianfeng Yang, Yu, Runze, Cheng, Cheng, Huo, Jian, Zhengyan Gong, Cao, Hanbing, Hu, Yu, Dai, Bingling, Yanmin Zhang · 2024 · Figshare
Additional file 1 of Cellular and clinical impact of protein phosphatase enzyme epigenetic silencing in multiple cancer tissues
Edward Wiltshire, Manuel Castro de Moura, David Piñeyro, Ricky S. Joshi · 2024 · Figshare
Additional file 2 of Cellular and clinical impact of protein phosphatase enzyme epigenetic silencing in multiple cancer tissues
Edward Wiltshire, Manuel Castro de Moura, David Piñeyro, Ricky S. Joshi · 2024 · Figshare
Additional file 1 of Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors
Tang, Xiaojia, Kevin J. Thompson, Kalari, Krishna R., Jason P. Sinnwell, Vera Jean Suman, Peter T. Vedell, Sarah A. McLaughlin, Donald W. Northfelt, Aspitia, Alvaro Moreno, Gray, Richard J. et al. · 2023 · Figshare
Additional file 2 of A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers
Tonći Šuštić, van Wageningen, Sake, Evert Bosdriesz, Robert J. D. Reid, John C. Dittmar, Cor Lieftink, Roderick L. Beijersbergen, Lodewyk F.A. Wessels, Rodney J. Rothstein, René Bernards · 2018 · Figshare
Cell death mechanisms of Marmycin A and Salinomycin in cancer cells
Trang Thi Mai · 2016 · theses.fr (ABES)
Échapper à la mort cellulaire dans le cancer : mitophagie et régulation de la mort indépendante des caspases
Elodie Villa · 2017 · theses.fr (ABES)
Pharmacogenomic and High-Throughput Data Analysis to Overcome Triple Negative Breast Cancers Drug Resistance
Benjamin Sadacca · 2017 · theses.fr (ABES)
Epigenetic characterization of cellular pliancy in breast cancer
Rahma Benhassoun · 2024 · theses.fr (ABES)
3D EM uncovers mitochondrial network remodeling in residual triple negative breast cancer after conventional chemotherapy treatments
Mariah J. Berner, Heather K. Beasley, Benjamin Rodriguez, Audra Lane, Steven W. Wall, Andrea Gail Marshall, Zer Vue, Larry Vang, Mokryun L. Baek, Mason Killion et al. · 2026 · iScience
Extracellular signal-regulated kinase signaling and breast cancer
Nitin Rajan, Neeraj Mishra, Nimisha Srivastava · 2026 · Elsevier eBooks
BindingDB Entry 50045861: Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer.
BindingDB · 2016 · UC San Diego